76 related articles for article (PubMed ID: 23474368)
1. Heterogeneity-corrected vs -uncorrected critical structure maximum point doses in breast balloon brachytherapy.
Kim L; Narra V; Yue N
Med Dosim; 2013; 38(2):196-8. PubMed ID: 23474368
[TBL] [Abstract][Full Text] [Related]
2. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
[TBL] [Abstract][Full Text] [Related]
3. Objective method to report planner-independent skin/rib maximal dose in balloon-based high dose rate (HDR) brachytherapy for breast cancer.
Kim Y; Trombetta MG
Med Phys; 2011 Apr; 38(4):2053-7. PubMed ID: 21626938
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric experience with 2 commercially available multilumen balloon-based brachytherapy to deliver accelerated partial-breast irradiation.
Fu W; Kim JO; Chen AS; Mehta K; Pucci P; Huq MS
Med Dosim; 2015; 40(3):195-200. PubMed ID: 25542786
[TBL] [Abstract][Full Text] [Related]
5. Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy.
Huang YJ; Su FF; Gaffney DK; Kokeny KE; Zhao H; Rassiah-Szegedi P; Salter BJ; Poppe MM
Brachytherapy; 2018; 17(6):956-965. PubMed ID: 30236908
[TBL] [Abstract][Full Text] [Related]
6. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric evaluation of multilumen intracavitary balloon applicator rotation in high-dose-rate brachytherapy for breast cancer.
Kim Y; Trombetta MG
J Appl Clin Med Phys; 2014 Jan; 15(1):4429. PubMed ID: 24423837
[TBL] [Abstract][Full Text] [Related]
8. Contura Multi-Lumen Balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial.
Arthur DW; Vicini FA; Todor DA; Julian TB; Cuttino LW; Mukhopadhyay ND
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):264-9. PubMed ID: 23433798
[TBL] [Abstract][Full Text] [Related]
9. A comparison of skin and chest wall dose delivered with multicatheter, Contura multilumen balloon, and MammoSite breast brachytherapy.
Cuttino LW; Todor D; Rosu M; Arthur DW
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):34-8. PubMed ID: 20350796
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer.
Major T; Niehoff P; Kovács G; Fodor J; Polgár C
Radiother Oncol; 2006 Jun; 79(3):321-8. PubMed ID: 16730085
[TBL] [Abstract][Full Text] [Related]
11. Point: balloon versus strut brachytherapy-which device offers the most dose modulation capability and normal tissue sparing?
Cuttino LW
Brachytherapy; 2011; 10(6):433-5. PubMed ID: 22051405
[No Abstract] [Full Text] [Related]
12. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
Wang Z; Jaggernauth W; Malhotra HK; Podgorsak MB
Med Dosim; 2010; 35(4):269-73. PubMed ID: 19944586
[TBL] [Abstract][Full Text] [Related]
13. Optimization and comparison of balloon-based partial breast brachytherapy using a single source, a standard plan line source, and both forward and inverse planned multilumen techniques.
Eyre K; Whitney D; Mukesh M; Wilson C; Coles C
Brachytherapy; 2013; 12(2):107-13. PubMed ID: 22732322
[TBL] [Abstract][Full Text] [Related]
14. The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments.
Boman EL; Satherley TWS; Schleich N; Paterson DB; Greig L; Louwe RJW
Brachytherapy; 2017; 16(6):1280-1288. PubMed ID: 28967561
[TBL] [Abstract][Full Text] [Related]
15. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses.
Ott OJ; Lotter M; Sauer R; Strnad V
Strahlenther Onkol; 2007 Aug; 183(8):426-31. PubMed ID: 17680222
[TBL] [Abstract][Full Text] [Related]
16. Seed Placement in Permanent Breast Seed Implant Brachytherapy: Are Concerns Over Accuracy Valid?
Morton D; Hilts M; Batchelar D; Crook J
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1050-1057. PubMed ID: 27020105
[TBL] [Abstract][Full Text] [Related]
17. Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy.
Berger D; Kauer-Dorner D; Seitz W; Pötter R; Kirisits C
Brachytherapy; 2008; 7(4):320-6. PubMed ID: 18928925
[TBL] [Abstract][Full Text] [Related]
18. MammoSite multilumen catheter: dosimetry considerations.
Ravi A; Lee S; Karsif K; Osian A; Nori D
J Cancer Res Ther; 2011; 7(1):64-8. PubMed ID: 21546745
[TBL] [Abstract][Full Text] [Related]
19. Consequences of dose heterogeneity on the biological efficiency of ¹⁰³Pd permanent breast seed implants.
Afsharpour H; Reniers B; Landry G; Pignol JP; Keller BM; Verhaegen F; Beaulieu L
Phys Med Biol; 2012 Feb; 57(3):809-23. PubMed ID: 22252246
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy.
Vijande J; Ballester F; Ouhib Z; Granero D; Pujades-Claumarchirant MC; Perez-Calatayud J
Brachytherapy; 2012; 11(6):528-35. PubMed ID: 22226080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
